Nano4Med is well-positioned to contribute to the evolving dialogue at the intersection of science, policy, and innovation in the field of advanced nanomaterials for biomedical applications. With strong interdisciplinary expertise and active involvement in EU initiatives, our group helps shape safe, effective, and forward-looking pathways for the clinical translation of nanotechnologies. We are open to collaboration with policy-makers, regulatory bodies, and industry stakeholders, offering expert input on the development, assessment, and responsible implementation of next-generation nanomaterials in healthcare.